Zentalis Pharmaceuticals, Inc. Shares of Common Stock ($0.001 par value per share) SALES AGREEMENTSales Agreement • May 4th, 2021 • Zentalis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 4th, 2021 Company Industry JurisdictionZentalis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC (the “Agent”), as follows: